Last reviewed · How we verify

NCT02847793: ABMET

Attentional Bias Modification Through Eye-tracker Methodology (ABMET)

Completed NA Last updated 10 October 2018
What this trial tests

NA trial testing Gaze training in Cognitive Deficits in 32 participants. Completed in 28 July 2017.

Timeline
1 April 2016
Primary endpoint
1 April 2017
28 July 2017

Quick facts

Lead sponsorUniversidad Complutense de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment32
Start date1 April 2016
Primary completion1 April 2017
Estimated completion28 July 2017
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Complutense de Madrid — full company profile →

Who can join

18 and older, any sex, with Cognitive Deficits or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive biases are a hallmark of depression but there is scarce research on whether these biases can be directly modified by using specific cognitive training techniques. The aim of this study will be targeting and modifying specifically relevant attention biases in participants with subclinical depression using eye-tracking methodologies. This innovative approach has been proposed as a promising future line of intervention in Attention Bias Modification procedures (Koster \& Hoorelbeke, 2015). Recent findings suggest that depression is characterized by a double attentional bias (Duque \& Vazquez, 2015), More specifically, depressed individuals have difficulties both to disengage from negative materials (e.g., sad faces) and to engage with positive materials (e.g., happy faces). Thus, training procedures to change attentional biases should target these two separate components.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Attentional bias modification in depression through gaze contingencies and regulatory control using a new eye-tracking intervention paradigm: study protocol for a placebo-controlled trial.
    Vazquez C, Blanco I, Sanchez A, McNally RJ. · · 2016 · cited 20× · PMID 27931196 · DOI 10.1186/s12888-016-1150-9

Verify or expand the search:

Other trials of Gaze training

Trials testing the same drug.

Other recruiting trials for Cognitive Deficits

Currently open trials in the same condition.

Other Universidad Complutense de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02847793.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing